BioInsights - Made-for-purpose manufacturing solutions - The key to commercialization
Jan
31
2019
On demand

Made-for-purpose manufacturing solutions - The key to commercialization

Sponsor
Made-for-purpose manufacturing solutions - The key to commercialization

With an ever increasing number of cell and gene therapies approaching commercialization, the key needs for the industry in terms of improved manufacturing equipment are threefold: GMP-ready equipment, process scalability and affordability.

Until now, the industry largely relied upon retrofitting existing equipment from the blood processing and biologics sectors to fit its needs. In order to truly see a step change in improved manufacturing it is crucial for tool providers to design equipment specifically for the GMP environment. Watch this On Demands webinar with Nina Bauer, Brian Dutra and Shirae Leslie of FloDesign Sonics as they reveal the latest data on the development of the most cutting edge of novel bioprocessing tools. During the webinar, they discuss:

  • Manufacturing cost drivers and key risk factors to commercial success.
  • Current State of Affairs in manufacturing technologies
  • How can we achieve commercially viable routine in manufacturing?
  • What is acoustophoresis and why is it important to cell processing?

Nina Bauer

Dr Nina Bauer

VP Business Development, FloDesign Sonics Inc

Nina Bauer, a key figure in the cell and gene therapy community joined FloDesign Sonics in September as VP of Business Development. She leads the commercial aspects of establishing, launching, and further adoption of this disruptive technology. Previously Nina led Lonza’s Autologous Cell Therapy business, with manufacturing sites in the US and Europe. As part of this role, she was also in charge of establishing novel manufacturing technologies, most notably the Octane Cocoon™ platform. Prior to joining Lonza, Nina held business development roles at the Cell Therapy Catapult (London), and the University of Edinburgh, and worked as Life Science Consultant for regenerative medicine businesses.

Brian Dutra

Brian Dutra

Senior R&D Engineer FloDesign Sonics

Brian is Senior R&D Engineer working to convert novel acoustic filtration technology to products to resolvemajor pain points in biopharmaceutical and cell therapy manufacturing industries in a startupenvironment. Leading several design efforts consisting of development of acoustic-fluidic filtrationelements. His work includes mechanical, electrical, and software development plus handling logistics of working with vendors and customers.

Shirae Leslie

Shirae Leslie

Senior Cell Processing Engineer FloDesign Sonics

Shirae Leslie, PhD is a Senior Cell Processing Engineer at FloDesign Sonics who works with the affinity team on developing the Acoustic Activated Cell Separation application for the ekko™ platform. Shirae believes that biomedical research should pave the way for transformative technologies that drastically improve patient care. She has developed a novel cell-based therapy to treat musculoskeletal defects which led to a patent, European patent filings Shirae holds a BS in Chemistry from Randolph Macon Woman’s College, Masters in Biomedical Engineering from Georgia Institute of Technology and a PhD in Chemical Engineering from Virginia Commonwealth University.

SPEAKERS

Nina Bauer
Nina Bauer
Head, Commercial, Gene Editing & Novel Modalities at MilliporeSigma
Brian Dutra
Brian Dutra
Senior R&D Engineer at MilliporeSigma
 Shirae Leslie
Shirae Leslie
Senior Cell Processing Engineer at MilliporeSigma